Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Petra Schneiderova, Tomas Pika, Petr Gajdos, Regina Fillerova, Pavel Kromer, Milos Kudelka, Jiri Minarik, Tomas Papajik, Vlastimil Scudla, Eva Kriegova
Published Aug 12, 2016 · Vol. 8, No. 41 · pp. 69408-69421
Anna Caliò, John N. Eble, Ondrej Hes, Guido Martignoni, Saul E. Harari, Sean R. Williamson, Matteo Brunelli, Adeboye O. Osunkoya, Lisha Wang, Eva Comperat, Antonio Lopez-Beltran, Mingsheng Wang, Shaobo Zhang, Kendra L. Curless, Kristin M. Post, Hsim-Yee Chang, Claudio Luchini, Lee Ann Baldrige, Gregory T. MacLennan, Rodolfo Montironi, David J. Grignon, Liang Cheng
Published Aug 8, 2016 · Vol. 8, No. 33 · pp. 54096-54105